A clinical guide to common drug-nutrient interactions

A comprehensive white paper on includes a review of current evidence that substantiates and/or theoretically supports the existence of interactions between commonly prescribed pharmaceutical medications and various nutrients or botanical extracts.

Treatment adherence white paper

A comprehensive literature review and industry insights: a brief report.

Supplement quality white paper

In order to improve the outlook and legitimacy of the supplement industry, establishing quality programs are of utmost importance. Quality programs are designed to ensure product and ingredient safety and effectiveness, as well as to create transparency in sourcing, manufacturing, distribution, and clinical settings.

Dietary supplements

From nutraceuticals to botanicals to multi-ingredient formulations, there’s no shortage of options for practitioners interested in recommending supplements, and the industry continues to innovate at an incredible pace. With thousands of products available through Fullscript, it’s sometimes difficult to know where to start.

Addressing pharmaceutical interactions in clinical practice

This guide includes the unintended consequences of pharmaceutical interventions and key pharmaceutical medication interactions and side effects.

Drug-nutrient depletions

Learn how to safely and effectively prescribe nutrients associated to pharmaceutical-induced depletions.

Supplement quality practitioner guide

The term “quality” is tossed around so much that it has almost lost its meaning. And yet, when it comes to purchasing and recommending dietary supplements, there is nothing more important than quality. But what constitutes a high-quality product?

Treatment adherence in integrative medicine

Learn more about the process of medication adherence and its management, factors influencing adherence, and top strategies for improving medication adherence.

Drug-nutrient depletions

The chart included in this handout primarily includes drug-nutrient depletions for which evidence from systematic reviews, meta-analyses, and randomized, double-blind, placebo-controlled, or randomized controlled human trials were available, the 21 pharmaceuticals included in this table are among the top-selling medications in the United States.